WANBURY
Back to Cashflow Statement
|
WANBURY Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹26 Cr | ₹14 Cr | ₹-32 Cr | ₹-29 Cr | ₹-17 Cr |
What is the latest Cash Flow from Financing Activities ratio of WANBURY ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹14 Cr |
| Mar2023 | ₹-32 Cr |
| Mar2022 | ₹-29 Cr |
| Mar2021 | ₹-17 Cr |
How is Cash Flow from Financing Activities of WANBURY Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹26 Cr | 85.50 | |
| Mar2024 | ₹14 Cr | Positive | |
| Mar2023 | ₹-32 Cr | Negative | |
| Mar2022 | ₹-29 Cr | Negative | |
| Mar2021 | ₹-17 Cr | - | |
Compare Cash Flow from Financing Activities of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹830.8 Cr | -7.1% | -6.5% | -9.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,068.0 Cr | -0.2% | 7.1% | 1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,847.0 Cr | 0.8% | -6% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,985.0 Cr | 1.2% | 6.4% | 13.1% | Stock Analytics | |
| CIPLA | ₹122,826.0 Cr | -0.2% | 1.4% | -0.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,418.0 Cr | 1.2% | 5.8% | 4.2% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -7.1% |
-6.5% |
-9.9% |
| SENSEX | 0% |
2.7% |
6.8% |
You may also like the below Video Courses